Fucose-modified thermoresponsive poly(2-hydroxypropyl methacrylate) nanoparticles for controlled doxorubicin release from an injectable depot

7Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

The modification of poly(2-hydroxypropyl methacrylate) with a single fucose group per polymer chain enabled macromolecular self-assembly, and the formation of thermoresponsive nanoparticles. In addition, poly(2-hydroxypropyl methacrylate)200 formed a self-healing material that may act as an injectable vehicle and depot for poly(2-hydroxypropyl methacrylate) nanoparticle delivery and localisation at a particular site. In combination, the injectable depot permits the controlled release of doxorubicin from the fucose presenting nanoparticles that it contains following injection. Such thermoresponsive materials are highly promising candidates for the treatment of diseases that may be remedied by exploiting targeted fucose-cell binding, such as pancreatic cancer.

Cite

CITATION STYLE

APA

Yu, H., Rowley, J. V., Green, D. C., & Thornton, P. D. (2020). Fucose-modified thermoresponsive poly(2-hydroxypropyl methacrylate) nanoparticles for controlled doxorubicin release from an injectable depot. Materials Advances, 1(5), 1293–1300. https://doi.org/10.1039/d0ma00280a

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free